SALT LAKE CITY, June 2 /PRNewswire/ — Amedica Corporation,
a spinal and orthopaedic implant and instrument manufacturer
focused on unique silicon nitride (SiN) ceramic technologies,
announced today that it has been granted United States Patent No.
7,695,521 covering its novel hip implant featuring a monoblock
ceramic acetabular cup for use in articulating joints for total
joint replacement. Currently under development, Amedica’s cup
covered under this and other pending patents will be used as an
ultralow-wear-bearing component for motion-preserving implants.
According to Ben Shappley, Chief
Executive Officer, President and Director of Amedica, the unique
ceramic manufacturing capability of the technology will help
surgeons to achieve more successful outcomes in restoring patient
function, allowing individuals to return to productive and
pain-free lives.
“Our unique technology allows us to combine our high-strength
silicon nitride ceramic with an ultralow-wear surface-bearing
technology along with a bone-contacting Bioactive™ surface
designed for secure, long-term fixation,” said Shappley.
“This provides surgeons with wider design choices and
flexibility to improve anatomic fit and function compared to
currently available alternate bearing options.”
Amedica is a full-line manufacturer and supplier of silicon
nitride ceramic technologies that are used in spinal implant
applications. The company has recently entered into a joint venture
agreement with Orthopaedic Synergies Inc., a global hip and knee
concern.
In addition to spinal implants, Amedica’s unique SiN materials
have disruptive characteristics for hip and knee implant
applications, as well. The material is fracture resistant; its
articulating
‘/>”/>
